Matthew HaugheyAn mRNA cancer cure is the next trillion dollar medical innovation that can save millions of lives and the US pulling the plug on researchers getting close to it is basically the stupidest move possible.
I hate that medical care in the US is profit driven but president business letting the Netherlands or China finish mRNA cures out from under the US is quite the own goal.
"we were like 2-3 years away from finishing landmark cures that would change the medical field forever, but the leader wanted to put another coat of gold paint on his ballroom so instead he canceled the funding" is something you might read in a gilded age novel
David Herrold@mathowie Many of the current administrations voters are at the "find out" stage of life right now.
Paul Horn@davidherrold @mathowie … or death.
Mike McCaffrey 
@davidherrold @mathowie If only the rest of us didn't need to find out as well.
@mikemccaffrey Yeah, unfortunately we're all in that terrifying rollercoaster now. Some people are screaming "I HAD NO IDEA" and others are screaming "I TOLD YOU SO" but the coaster isn't stopping anytime soon.
Christopher Faille@mathowie Sounds like the premise for a Ferengi-empire based episode of Deep Space Nine.
sharon linne faulk@mathowie I bet he thinks there isn’t enough gold on that show “It’s called the Gilded Age? Why isn’t EVERYTHING gilded in gold?”
PhosphenesI just hope to God other countries DO finish the work.
i_give_u_worms@mathowie it's only important if you want people to live, but if you want to run death camps it's an expense that bothers you while you sit on a solid gold toilet
fabriek@mathowie The Dutch government is also making huge cuts to science, so unfortunately we won't be doing it either.
rednikki@mathowie Now the US is also working to force other countries to pay the same prices for medications that the US does. Because drug companies don’t make enough profit already.
Part of the reason drug prices in other countries are lower is that the US allows companies to play games with formulations and delivery methods in order to keep their patents, even if those changes don’t actually change how the medication performs. Other countries do not allow that.
Remember when Trump promised on the campaign trail that people in the US would pay the same amount for medications that people in other countries do? Well, this is one way to stick to that promise, I guess.
We are simultaneously killing the goose that laid the golden egg and trying to squeeze as much gold out of the remaining eggs as possible.
(PBS in the context of this article stands for “pharmacy benefits scheme.”)
https://www.thesaturdaypaper.com.au/news/health/2025/08/02/exclusive-australia-engage-us-lobbyists-defend-pbs?utm_campaign=SharedArticle&utm_source=share&utm_medium=link&utm_term=VEVgFCVm&token=VPs53lvm
Exclusive: Australia to engage US lobbyists to defend PBS
Australia’s Pharmaceutical Benefits Scheme is squarely in the crosshairs of United States Republican senators and the American pharmaceutical industry, who are ramping up pressure on the Trump administration to end what they describe as global “free-riding” on American-funded drug innovation. At stake is the future of the PBS, a system that has long delivered Australians some of the cheapest prices for medicines in the developed world and which now risks becoming a casualty of a broader US effort to recast global pharmaceutical pricing through trade leverage.